Stock Rating Downgrade
During the last several trading days the Value Trend Rating for Tonix Pharmaceuticals Holding Co (NASDAQ: TNXP) weakened from B to C reflecting eroding fundamentals and low Appreciation Potential.
Recent Price Action
Tonix Pharmaceuticals Holding Co (NASDAQ: TNXP) stock closed at $28.61 on 9/12/25 after a large decline of -8.3%. However, this decline was accompanied by exceptionally low trading volume at -2% of normal. The stock has risen 8.7% during the last week and has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
Tonix Pharmaceuticals Holding has a current Value Trend Rating of C (High Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Tonix Pharmaceuticals Holding has a poor Appreciation Score of 24 but a very high Power Rating of 94, producing the High Neutral Value Trend Rating.
Be the first to comment